Skip to main content

Polymyalgia Rheumatica, Giant Cell Arteritis, and Vascular Complications

  • Chapter
  • First Online:
  • 664 Accesses

Abstract

Polymyalgia rheumatica (PMR) may be associated with vascular complications for a number of reasons: 1/the inflammatory nature of the disease itself, 2/strong association with giant cell arteritis (GCA – which has a direct inflammatory effect on arteries and may result in either stenosis or aneurysm within affected segments), 3/side effect of the corticosteroid treatment (including arterial hypertension, dyslipidemia and/or diabetes mellitus). GCA is a systemic granulomatous vasculitis, typically affecting branches of carotid artery mainly temporal artery; however, any other medium or large artery can be affected. This fact complicates diagnosis of the disease. Diagnostic possibilities of GCA are discussed in this chapter.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hancock AT, Mallen CD, Belcher J, Hider SL. Association between polymyalgia rheumatic and vascular diseases: a systemic review. Arthritis Care Res. 2012;64(9):1301–5.

    Article  Google Scholar 

  2. Kremers HM, Reinalda MS, Crowson CS, Davis JM, Hunder GG, Gabriel SE. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatic. Arthritis Rheum. 2007;57:279–86.

    Article  CAS  Google Scholar 

  3. Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatic. Br J Rheumatol. 1995;34:261–4.

    Article  CAS  PubMed  Google Scholar 

  4. Uddhammar A, Eriksson A, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29:737–42.

    PubMed  Google Scholar 

  5. Warrington KJ, Jarpa EP, Crowson CS, Cooper LT, Hunder GG, Matteson EL, et al. Increased risk of peripheral arterial disease in polymyalgia rheumatic: a population based cohort study. Arthritis Res Ther. 2009;11:50.

    Article  Google Scholar 

  6. Murphy EA, Capell H. Aortitis and large vessel vasculitides. In: Tooke JE, Lowe GDO, editors. A textbook of vascular medicine. London: Arnold; 1996. p. 287–94.

    Google Scholar 

  7. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.

    Article  PubMed  Google Scholar 

  8. Rovenský J, Tauchmannová H, Štvrtinová V, Štvrtina S, Duda J. Polymyalgia rheumatica a obrovskobunková arteritída, príspevok ku klinicko-laboratórnej syndromológii a terapii. Čes Revmatol. 2006;14(3):135–43.

    Google Scholar 

  9. Bengtsson BA. Giant cell arteritis. In: Ansell BM, Bacon PA, Lie JT, Yazici H, editors. The vasculitides. Science and practice. London: Chapman and Hall Medical; 1996. p. 171–80.

    Chapter  Google Scholar 

  10. Lie JT. Coronary vasculitis. A review in the current scheme of classification of vasculitis. Arch Pathol Lab Med. 1987;111(3):224–33.

    CAS  PubMed  Google Scholar 

  11. Weyand CM, Goronzy JJ. Pathogenetic principles in giant cell arteritis. Int J Cardiol. 2000;75(Suppl 1):S9–15.

    Article  PubMed  Google Scholar 

  12. Jennette IC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;17(2):187–92.

    Article  Google Scholar 

  13. Lie JT, Failoni DD, Davis DC. Temporal arteritis with giant cell aortitis, coronary arteritis, and myocardial infarction. Arch Pathol Lab Med. 1986;110(9):857–60.

    CAS  PubMed  Google Scholar 

  14. Štvrtina S, Rovenský J, Galbavý Š. Aneuryzma aorty ako príčina smrti pri obrovskobunkovej arteritíde. Rheumatologia. 2003;17(3):213–20.

    Google Scholar 

  15. Lie JT. Aortic and extracranial large vessel giant eel arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995;24(6):422–31.

    Article  CAS  PubMed  Google Scholar 

  16. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11:A544–54.

    Article  PubMed  Google Scholar 

  17. Pipinos II, Hopp R, Edwards WD, Radio SJ. Giant cell temporal arteritis in a 17-year-old male. J Vasc Surg. 2006;43(5):1053–5.

    Article  PubMed  Google Scholar 

  18. Rovenský J, Tauchmannová H, Štvrtinová V, Štvrtina S. Príspevok k problematike juvenilnej temporálnej arteritídy. Rheumatologia. 2005;19(4):153–5.

    Google Scholar 

  19. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum. 1981;24:899–904.

    Article  CAS  PubMed  Google Scholar 

  20. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25-year epidemiologic, clinical and pathologic study. Ann Intern Med. 1978;88(2):162–7.

    Article  CAS  PubMed  Google Scholar 

  21. Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990 to 2001. Ann Rheum Dis. 2006;65(8):1093–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kermani TA, Schafer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780–1.

    Article  PubMed  Google Scholar 

  23. Interpolated demographic indicators by major area, region and country, annually for 1950–2100. Medium Fertility variant, 2010–2100. http://esa.un.org/wpp/Excel-Data/Interpolated.htm. Accessed 4 Jan 2014.

  24. De Smit E, Palmer AJ, Hewitt AW. Projected worldwide disease burden from giant cell arteritis by 2050. J Rheumatol. 2015;42:119–125. doi:10.3899/jrheum.140318 [PubMed].

  25. Rovenský J, Štvrtinová V, Tauchmannová H, Duda J. Polymyalgia rheumatica and giant cell arteritis—importance of factors contributing to severity of disease. Rheuma 21st, Archived Reports. www.rheuma21st.com/archives/cutting

  26. Lee SJ, Kavanaugh Α. Autoimmunity, vasculitis and autoantibodies. J Allergy Clin Immunol. 2006;117(2):S445–50.

    Article  CAS  PubMed  Google Scholar 

  27. Hellmann DB. Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. Curr Opin Rheumatol. 1993;5:25–32.

    Article  CAS  PubMed  Google Scholar 

  28. Imrich R, Bošák V, Rovenský J. Polymyalgia rheumatic a temporálna arteritída: vzťah hormónov k patogenéze. Rheumatologia. 2003;17(l):69–77.

    Google Scholar 

  29. Olsson Α, Elling P, Elling H. Synchronous variations of the incidence of arteritis temporalis and polymyalgia rheumatic in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. Clin Rheumatol. 1994;13(2):384.

    Google Scholar 

  30. Perfetto F, Moggi-Pignone M, Becucci A, et al. Seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis. 2005;64:1662–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Nordborg C, Nordborg E, Petursdottir V. The pathogenesis of giant cell arteritis: morphological aspects. Clin Exp Rheumatol. 2000;18(4 Suppl 20):S18–21.

    CAS  PubMed  Google Scholar 

  32. Nordborg C, Nordborg E, Petursdottir V, Fyhr IM. Calcification of the internal elastic membrane in temporal arteries:its relation to age and gender. Clin Exp Rheumatol. 2001;19(5):565–8.

    CAS  PubMed  Google Scholar 

  33. Weyand CM, Goronzy JJ. Pathogenetic mechanisms in giant cell arteritis. Cleve Clin J Med. 2002;69(Suppl 2):SII28–32.

    PubMed  Google Scholar 

  34. Kaiser M, Younge B, Bjornsson J, et al. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol. 1999;155(3):765–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33(8):1074–87.

    Article  CAS  PubMed  Google Scholar 

  36. Liu G, Shupak R, Chiu BK. Aortic dissection in giant cell arteritis. Semin Arthritis Rheum. 1995;25(3):160–71.

    Article  CAS  PubMed  Google Scholar 

  37. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995;122(7):502–7.

    Article  CAS  PubMed  Google Scholar 

  38. Karger B, Fechner G. Sudden death due to giant cell coronary arteritis. Int J Leg Med. 2006;120(6):377–9.

    Article  CAS  Google Scholar 

  39. Martin JF, Kittas C, Triger DR. Giant cell arteritis of coronary arteries causing myocardial infarction. Br Heart J. 1980;43(4):487–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Säve-Soderbergh J, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis as a cause of death. JAMA. 1986;255(4):493–6.

    Article  PubMed  Google Scholar 

  41. Polak P, Pokorný V, Štvrtina S, et al. Temporal arteritis presenting with paresis of the oculomotor nerve and polymyalgia rheumatica, despite a low erythrocyte sedimentation rate. J Clin Rheumatol. 2005;11(4):242–4.

    Article  PubMed  Google Scholar 

  42. Dupuy R, Mercié P, Neau D, et al. Giant cell arteritis involving the lower limbs. Rev Rheum Engl Ed. 1997;64:500–3.

    CAS  Google Scholar 

  43. Garcia Vázques JM, Carreira JM, Seoane C, et al. Superior and inferior limb ischemia in giant cell arteritis: angiography follow up. Clin Rheumatol. 1999;18:61–5.

    Article  Google Scholar 

  44. Le Hello C, Lévesque H, Leanton M, et al. Lower limb giant cell arteritis and temporal arteritis: follow up of 8 cases. J Rheumatol. 2001;28(6):1407–11.

    PubMed  Google Scholar 

  45. Tato F, Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 2006;44(1):176–82.

    Article  PubMed  Google Scholar 

  46. Ungprasert P, Thongprayoon C, Kittanamongkolchal W, Srivali N, Cheungpasitporn W. Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis. Int J Rheum Dis. 2016;19(18):819–25. doi:10.1111/1756-185X.12631. Epub 2015 Jul 28. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  47. Aschwaden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356–9.

    Article  Google Scholar 

  48. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of the giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.

    Article  CAS  PubMed  Google Scholar 

  49. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92–101.

    Article  PubMed  Google Scholar 

  50. Schmidt WA, Gromica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour doppler ultrasound of the temporal arteries. Rheumatology (Oxford). 2002;41:46–52.

    Article  CAS  PubMed  Google Scholar 

  51. Meisner RJ, Labropoulos N, Gasparis AP, Tassiopoulos AK. How to diagnose giant cell arteritis. Int Angiol. 2011;30:58–63.

    CAS  PubMed  Google Scholar 

  52. Kolossváry E, Kollár Α, Pintér Η, et al. Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis: important role of color duplex ultrasonography in the diagnosis. Int Angiol. 2005;24(2):202–5.

    PubMed  Google Scholar 

  53. Herve F, Choussy V, Janvresse A, et al. Aortic involvement in giant cell arteritis. A prospective follow-up of 11 patients using computed tomography. Rev Med Interne. 2006;27(3):196–202.

    Article  CAS  PubMed  Google Scholar 

  54. Joyce JW. Arteritis. In: Eastcott HHG, editor. Arterial surgery. Madrid: Churchill Livingstone; 1992. p. 211–22.

    Google Scholar 

  55. Štvrtinová V, Rauová L, Tuchyňová Α, Rovenský J. Vasculitis of the coronary arteries and atherosclerosis: random coincidence or causative relationship? In: Shoenfeld Y, Harats D, Wick G, editors. Atherosclerosis and autoimmunity. Amsterdam: Elsevier; 2001. p. 315–27.

    Chapter  Google Scholar 

  56. Nesher G, Sonnenblick M. Steroid-sparing medications in temporal arteritis—report of three cases and review of 174 reported patients. Clin Rheumatol. 1994;13(2):289–92.

    CAS  PubMed  Google Scholar 

  57. Tuchyňová Α, Rovenský J, Mičeková D. Polymyalgia rheumatica a temporálna arteritída—klinický obraz a liečba. Rheumatologia. 1998;12(3):117–22.

    Google Scholar 

  58. Gonzales-Juanatey C, Llorca J, Garcia-Porrua C, et al. Steroid therapy improves endothelial function in patients with biopsy, proven giant cell arteritis. J Rheumatol. 2006;33(1):74–8.

    Google Scholar 

  59. Both M, Aries PM, Muller-Hulsbeck S, et al. Balloon angioplasty of upper extremity in patients with extracranial giant cell arteritis. Ann Rheum Dis. 2006;65(9):1124–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Viera Štvrtinová M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Štvrtinová, V., Čelovská, D., Štvrtina, S., Rovenský, J. (2017). Polymyalgia Rheumatica, Giant Cell Arteritis, and Vascular Complications. In: Rovenský, J., Leeb, B., Štvrtinová, V., Imrich, R. (eds) Polymyalgia Rheumatica and Giant Cell Arteritis. Springer, Cham. https://doi.org/10.1007/978-3-319-52222-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52222-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52221-0

  • Online ISBN: 978-3-319-52222-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics